MIRALAX

LOE Approaching

polyethylene glycol 3350

NDAORALFOR SOLUTION

Approved

Feb 1999

Lifecycle

LOE Approaching

Competitive Pressure

30/100

Clinical Trials

NCT03060512Phase 4Completed

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Started Mar 2017

276 enrolled

Opioid Induced Constipation

NCT02292459Phase 3Withdrawn

Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)

Started Dec 2015

Constipation

NCT01707667Phase 4Completed

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

Started Feb 2013

13 enrolled

Chronic Constipation

NCT01212445Phase 2Completed

Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)

Started Oct 2010

154 enrolled

Constipation

External Resources